KalVista Pharmaceuticals (KALV) Stock Chart & Stock Price History $10.71 -0.61 (-5.39%) Closing price 04:00 PM EasternExtended Trading$10.71 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KalVista Pharmaceuticals Stock Price Performance 5 Day Performance-13.20%1 Month Performance-8.12%3 Month Performance+14.67%6 Month Performance-8.85%Year-To-Date Performance+22.26%1 Year Performance-7.63% Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address KALV Stock Chart for Friday, April, 4, 2025 KALV Chart by TradingViewRemove Ads KalVista Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/03/2025$11.09$11.32+2.07%$11.36$10.55909,988 shs$562.79 million04/02/2025$11.15$11.09-0.54%$11.49$10.84918,573 shs$551.35 million04/01/2025$11.54$11.15-3.38%$11.78$11.02831,980 shs$554.33 million03/31/2025$11.93$11.54-3.27%$11.76$11.05440,751 shs$573.72 million03/28/2025$12.34$11.93-3.32%$12.50$11.82275,700 shs$593.11 million03/27/2025$12.07$12.34+2.24%$12.39$12.00466,170 shs$613.50 million03/26/2025$12.50$12.07-3.44%$12.43$11.96501,879 shs$600.07 million03/25/2025$12.25$12.50+2.04%$12.58$11.83838,237 shs$621.45 million03/24/2025$11.89$12.25+3.03%$12.42$11.90497,887 shs$609.02 million03/21/2025$12.00$11.89-0.92%$12.22$11.831.22 million shs$591.12 million Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/20/2025$12.10$12.00-0.83%$12.26$11.65525,112 shs$596.59 million03/19/2025$12.37$12.10-2.18%$12.48$11.92506,669 shs$601.56 million03/18/2025$12.49$12.37-0.96%$12.48$11.82344,637 shs$614.99 million03/17/2025$12.60$12.49-0.87%$12.74$12.28475,527 shs$617.23 million03/14/2025$12.25$12.60+2.86%$12.63$11.96437,380 shs$622.67 million03/13/2025$12.45$12.25-1.61%$12.57$11.96403,080 shs$605.37 million03/12/2025$12.43$12.45+0.16%$12.90$12.29666,072 shs$615.25 million03/11/2025$11.99$12.43+3.67%$12.67$11.76733,168 shs$614.27 million03/10/2025$11.92$11.99+0.59%$12.25$11.53597,319 shs$592.52 million03/07/2025$11.98$11.92-0.50%$12.20$11.74595,472 shs$589.06 million03/06/2025$11.61$11.98+3.19%$12.05$11.42572,979 shs$592.03 million03/05/2025$11.27$11.61+3.02%$11.63$11.00865,357 shs$573.74 million03/04/2025$10.87$11.27+3.68%$11.52$10.54823,083 shs$556.94 million03/03/2025$11.40$10.87-4.65%$11.75$10.711.06 million shs$537.17 million Related Companies GMTX Stock Price Chart NAMS Stock Price Chart VCEL Stock Price Chart MIRM Stock Price Chart RXRX Stock Price Chart BLTE Stock Price Chart EWTX Stock Price Chart DNLI Stock Price Chart TARS Stock Price Chart BEAM Stock Price Chart Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALV) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
